Stay updated on Fruquintinib & Tislelizumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Fruquintinib & Tislelizumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fruquintinib & Tislelizumab in Solid Tumors Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The page shows a new revision tag (v3.6.6) replacing the previous v3.6.5. This indicates a minor update to the page’s software or formatting rather than substantive content changes.
    Difference
    0.0%
    Check dated 2026-08-31T18:28:02.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.4 to v3.6.5 for the study record, indicating a new version of the page content.
    Difference
    0.0%
    Check dated 2026-08-10T12:40:37.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The page's revision tag has been updated from v3.6.3 to v3.6.4, indicating a new build of the page. This update appears to be an internal software revision without changes to the study details or how the page presents information to users.
    Difference
    0.0%
    Check dated 2026-07-27T05:23:10.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.2 to v3.6.3 on the page, indicating a newer build of the Study Details page. The update does not change the study content or user-facing information.
    Difference
    0.0%
    Check dated 2026-07-05T11:16:28.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    Revision updated from v3.6.0 to v3.6.2, indicating a page/template update. No study content, eligibility criteria, or results appear to be affected.
    Difference
    0.0%
    Check dated 2026-06-28T08:30:22.000Z thumbnail image
  9. Check
    92 days ago
    Change Detected
    Summary
    The page now shows that no participants are being recruited and adds user-focused sections such as How to Read a Study Record, Common Questions, and How to Join a Study, while updating the Intervention/Treatment heading formatting.
    Difference
    0.4%
    Check dated 2026-06-13T17:35:47.000Z thumbnail image

Stay in the know with updates to Fruquintinib & Tislelizumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fruquintinib & Tislelizumab in Solid Tumors Clinical Trial page.